BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11414605)

  • 1. Heparin-coated cardiopulmonary bypass circuit: clinical effects in pediatric cardiac surgery.
    Miyaji K; Hannan RL; Ojito J; Jacobs JP; White JA; Burke RP
    J Card Surg; 2000; 15(3):194-8. PubMed ID: 11414605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
    Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of biocompatible cardiopulmonary bypass circuit use during pediatric open heart surgery.
    Deptula J; Glogowski K; Merrigan K; Hanson K; Felix D; Hammel J; Duncan K
    J Extra Corpor Technol; 2006 Mar; 38(1):22-6. PubMed ID: 16637519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits.
    Kutay V; Noyan T; Ozcan S; Melek Y; Ekim H; Yakut C
    J Card Surg; 2006; 21(6):572-7. PubMed ID: 17073955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective randomized trial comparing the clinical effectiveness and biocompatibility of heparin-coated circuits and PMEA-coated circuits in pediatric cardiopulmonary bypass.
    Itoh H; Ichiba S; Ujike Y; Douguchi T; Kasahara S; Arai S; Sano S
    Perfusion; 2016 Apr; 31(3):247-54. PubMed ID: 26228276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit.
    Francalancia NA; Aeba R; Yousem SA; Griffith BP; Marrone GC
    J Heart Lung Transplant; 1994; 13(3):498-507. PubMed ID: 8061027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.
    Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M
    Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-coated bypass circuits: effects on inflammatory response in pediatric cardiac operations.
    Schreurs HH; Wijers MJ; Gu YJ; van Oeveren W; van Domburg RT; de Boer JH; Bogers AJ
    Ann Thorac Surg; 1998 Jul; 66(1):166-71. PubMed ID: 9692458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit can reduce transfusion of platelet products compared to heparin-coated circuit during aortic arch surgery.
    Hosoyama K; Ito K; Kawamoto S; Kumagai K; Akiyama M; Adachi O; Kawatsu S; Sasaki K; Suzuki M; Sugawara Y; Shimizu Y; Saiki Y
    J Artif Organs; 2016 Sep; 19(3):233-40. PubMed ID: 26909493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of heparin-coated circuits on the platelets during cardiopulmonary bypass.
    Zhang K; Hu Z; Yang Y; Huang R; Fan H; Sun Z
    J Huazhong Univ Sci Technolog Med Sci; 2003; 23(4):403-6. PubMed ID: 15015647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is a fully heparin-bonded cardiopulmonary bypass circuit superior to a standard cardiopulmonary bypass circuit?
    Mahmood S; Bilal H; Zaman M; Tang A
    Interact Cardiovasc Thorac Surg; 2012 Apr; 14(4):406-14. PubMed ID: 22228288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-bonded cardiopulmonary bypass circuits reduce cognitive dysfunction.
    Heyer EJ; Lee KS; Manspeizer HE; Mongero L; Spanier TB; Caliste X; Esrig B; Smith C
    J Cardiothorac Vasc Anesth; 2002 Feb; 16(1):37-42. PubMed ID: 11854876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-coated cardiopulmonary bypass circuits in coronary bypass surgery.
    Horimoto H; Kondo K; Asada K; Sasaki S
    Artif Organs; 1996 Aug; 20(8):936-40. PubMed ID: 8853810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of lipopolysaccharide toxicity-modulating proteins in patients undergoing cardiopulmonary bypass using noncoated and heparin-coated extracorporeal circuits. A clinical pilot study.
    Bouma M; Maessen J; Weerwind P; Dentener M; Fransen E; de Jong D; Buurman W
    Chest; 1997 Mar; 111(3):577-83. PubMed ID: 9118690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the additional use of heparin-coated extracorporeal circuits (ECC) optimize the effect of modified ultrafiltration (MUF) in pediatric perfusion?
    Harig F; Meier C; Hakami L; Strasser R; Bretzger J; Münch F; Vestweber-Wilmes E; Singer H; Weyand M; Cesnjevar R
    Thorac Cardiovasc Surg; 2006 Apr; 54(3):168-72. PubMed ID: 16639677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-coated circuits reduce the formation of TNF alpha during cardiopulmonary bypass.
    Yamada H; Kudoh I; Hirose Y; Toyoshima M; Abe H; Kurahashi K
    Acta Anaesthesiol Scand; 1996 Mar; 40(3):311-7. PubMed ID: 8721461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of heparin coated circuits upon metabolism in vital organs: effect upon cerebral and renal function during and after cardiopulmonary bypass.
    de Vroege R; Stooker W; van Oeveren W; Bakker EW; Huybregts RA; van Klarenbosch J; van Kamp GJ; Hack CE; Eijsman L; Wildevuur CR
    ASAIO J; 2005; 51(1):103-9. PubMed ID: 15745143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit possesses superior platelet preservation and inflammatory suppression efficacy.
    Ikuta T; Fujii H; Shibata T; Hattori K; Hirai H; Kumano H; Suehiro S
    Ann Thorac Surg; 2004 May; 77(5):1678-83. PubMed ID: 15111165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory response after coronary revascularization: off-pump versus on-pump (heparin-coated circuits and poly2methoxyethylacrylate-coated circuits).
    Hazama S; Eishi K; Yamachika S; Noguchi M; Ariyoshi T; Takai H; Odate T; Matsukuma S; Onohara D; Yanatori M
    Ann Thorac Cardiovasc Surg; 2004 Apr; 10(2):90-6. PubMed ID: 15209550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-coated circuits reduce myocardial injury in heart or heart-lung transplantation: a prospective, randomized study.
    Wan S; LeClerc JL; Antoine M; DeSmet JM; Yim AP; Vincent JL
    Ann Thorac Surg; 1999 Oct; 68(4):1230-5. PubMed ID: 10543484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.